» Articles » PMID: 32085857

A Common Clinical Conundrum: Antidepressant Treatment of Depression in Pregnant Women

Overview
Journal Semin Perinatol
Date 2020 Feb 23
PMID 32085857
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Depression during pregnancy is associated with adverse maternal, pregnancy, and infant outcomes. Treatment during pregnancy requires a balanced discussion of the risks of both drug exposure and untreated depression. An updated review of the epidemiology, outcomes, and management of maternal depression is presented. Adverse outcomes are associated with both maternal depression and antidepressants. Research gaps include data on the longitudinal developmental trajectory of offspring exposed to antidepressants compared to depression, with assessment of in utero symptom exposure and environmental exposures. Additionally, neonatal syndrome associated with antidepressant use during pregnancy has no consensus definition or mechanistic explanation. With sophisticated large-scale epidemiologic studies, there has been progress in distinguishing the impact of depression processes from medication used for treatment. Optimal treatment of perinatal depression includes close symptom monitoring and medication adjustments to maintain symptom remission. This evolving field requires frequent consultation with reproductive data sources included in this article.

Citing Articles

Vagus nerve stimulation: a physical therapy with promising potential for central nervous system disorders.

Wang C, Wu B, Lin R, Cheng Y, Huang J, Chen Y Front Neurol. 2024; 15:1516242.

PMID: 39734634 PMC: 11671402. DOI: 10.3389/fneur.2024.1516242.


Diet and the gut microbiota-immune axis in the context of perinatal mental health: Protocol for a prospective cohort study.

Wallace C, Audet M Womens Health (Lond). 2024; 20:17455057241277072.

PMID: 39287570 PMC: 11409294. DOI: 10.1177/17455057241277072.


Safety of electroconvulsive therapy (ECT) in pregnancy: a systematic review of case reports and case series.

Cipolla S, Catapano P, Messina M, Pezzella P, Giordano G Arch Womens Ment Health. 2023; 27(2):157-178.

PMID: 37957411 PMC: 10933171. DOI: 10.1007/s00737-023-01394-1.


Psychiatric illness and pregnancy: A literature review.

Abdelhafez M, Ahmed K, Ahmed N, Ismail M, Mohd Daud M, Ping N Heliyon. 2023; 9(11):e20958.

PMID: 37954333 PMC: 10632674. DOI: 10.1016/j.heliyon.2023.e20958.


Opportunities and challenges of pharmacovigilance in special populations: a narrative review of the literature.

Li Y, Wu Y, Jiang T, Xing H, Xu J, Li C Ther Adv Drug Saf. 2023; 14:20420986231200746.

PMID: 37780667 PMC: 10540608. DOI: 10.1177/20420986231200746.


References
1.
Yonkers K, Gotman N, Smith M, Forray A, Belanger K, Brunetto W . Does antidepressant use attenuate the risk of a major depressive episode in pregnancy?. Epidemiology. 2011; 22(6):848-54. PMC: 3188383. DOI: 10.1097/EDE.0b013e3182306847. View

2.
ODonnell K, Meaney M . Fetal Origins of Mental Health: The Developmental Origins of Health and Disease Hypothesis. Am J Psychiatry. 2016; 174(4):319-328. DOI: 10.1176/appi.ajp.2016.16020138. View

3.
Kulin N, Pastuszak A, Sage S, Spivey G, Feldkamp M, Ormond K . Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA. 1998; 279(8):609-10. DOI: 10.1001/jama.279.8.609. View

4.
Wisner K, Zarin D, Holmboe E, Appelbaum P, Gelenberg A, Leonard H . Risk-benefit decision making for treatment of depression during pregnancy. Am J Psychiatry. 2000; 157(12):1933-40. DOI: 10.1176/appi.ajp.157.12.1933. View

5.
Hipwell A, Goossens F, Melhuish E, Kumar R . Severe maternal psychopathology and infant-mother attachment. Dev Psychopathol. 2000; 12(2):157-75. DOI: 10.1017/s0954579400002030. View